ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2223

Improving collaboration between rheumatology and OBGYN in the reproductive health care of patients with rheumatic disease

Sara Heard1, Isha Vasudeva2, Juvena Hitt2 and Jeanne Gosselin3, 1University of Vermont Medical Center, Burlington, VT, 2University of Vermont Medical Center, Burlington, 3University of Vermont Medical Center, Waterbury, VT

Meeting: ACR Convergence 2025

Keywords: autoimmune diseases, Education, pregnancy, Women's health

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 28, 2025

Title: (2195–2226) Reproductive Issues in Rheumatic Disorders Posters

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Contraception management, preconception planning, and prenatal, antenatal, and postnatal care vary significantly in clinical practice for patients with rheumatic disease. Rheumatologists recognize the need for efficient referral systems to facilitate collaboration with reproductive health providers; however, they may not have professional relationships with obstetrician-gynecologist (OBGYN) colleagues and an established referral pathway. We conducted a needs assessment at our institution, including surveys of OBGYN residents and OBGYN generalists, to better understand their access to resources and referral patterns to maternal-fetal medicine (MFM) and rheumatology. This quality improvement project aims to improve collaboration between women’s health providers and rheumatologists to improve the reproductive health care of patients with rheumatic disease within our health system.

Methods: Online REDCap surveys were administered to OBGYN residents (N&#3f16, 9 pre-intervention, 7 post-intervention) and OBGYN generalists (N&#3f8). OBGYN residents and generalists were asked about resources and access to specialist (MFM and rheumatology) assistance when managing patients with rheumatic disease, when they refer patients to MFM and rheumatology, and preference for electronic versus in-person rheumatology consults. Our primary intervention was a lecture on reproductive health in rheumatic disease for OBGYN residents. Resident survey results were collected pre- and post-intervention and analyzed using Stata 18 software.

Results: Post-intervention data showed an increase in the percentage of OBGYN residents who feel they have the knowledge, skillset, and resources to manage patients with rheumatic disease during pregnancy, from 0% to 57%. The percentage of residents who knew when to refer patients with rheumatic disease to MFM and/or rheumatology increased from 0% to 100%, and those who felt they could identify teratogenic medications in patients with rheumatic disease increased from 33% to 86% post-intervention. Preconception, OBGYN generalists report referring patients with rheumatic disease to rheumatology only (50%), or to both rheumatology and MFM (33%), and less often to MFM only (17%). When referring patients to rheumatology, 50% of generalists choose in-person consults and 50% choose both in-person and electronic consults.

Conclusion: We implemented an effective educational intervention that improved OBGYN resident knowledge regarding when to refer patients to rheumatology, with post-intervention data showing a 100% increase from baseline. The intervention also increased the percentage of residents who felt they could identify teratogenic medications. The OBGYN generalist survey served as a needs assessment and showed that generalists typically refer patients to rheumatology, or both rheumatology and MFM, preconception. Next steps in this quality improvement project include examination of bidirectional referral pathways, indications for referral to rheumatology and OBGYN, and access to each specialty for urgent and non-urgent indications, including contraception and high-risk pregnancy management, to streamline referral processes and improve collaboration.

Supporting image 1Figure 1

Supporting image 2Figure 2

Supporting image 3Figure 3


Disclosures: S. Heard: None; I. Vasudeva: None; J. Hitt: None; J. Gosselin: None.

To cite this abstract in AMA style:

Heard S, Vasudeva I, Hitt J, Gosselin J. Improving collaboration between rheumatology and OBGYN in the reproductive health care of patients with rheumatic disease [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/improving-collaboration-between-rheumatology-and-obgyn-in-the-reproductive-health-care-of-patients-with-rheumatic-disease/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/improving-collaboration-between-rheumatology-and-obgyn-in-the-reproductive-health-care-of-patients-with-rheumatic-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology